Welcome to the international HTA database

Showing [21959 Records] Selected Records [0 Hits] [Clear]

Year	Source	Title
2016	NIHR Horizon Scanning Centre (NIHR HSC)	Irinotecan-eluting beads (DC Bead, DC Bead M1 and DC Bead Lumi) for liver metastases secondary to colorectal cancer
2016	NIHR Horizon Scanning Centre (NIHR HSC)	Lifitegrast for dry eye disease
2016	Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG)	[Ibrutinib (chronic lymphocytic leukaemia): benefit assessment according to §35a Social Code Book V]
2016	NIHR Horizon Scanning Centre (NIHR HSC)	Idelalisib in combination with bendamustine and rituximab for indolent non-Hodgkin lymphoma – second line
2016	NIHR Horizon Scanning Centre (NIHR HSC)	Nivolumab (Opdivo) for gastric and gastroesophageal junction adenocarcinoma – third and fourth line
2016	NIHR Horizon Scanning Centre (NIHR HSC)	rhPTH (Natpar) for hypoparathyroidism – adjunctive therapy
2016	NIHR Horizon Scanning Centre (NIHR HSC)	Ozanimod for relapsing remitting multiple sclerosis
2016	NIHR Horizon Scanning Centre (NIHR HSC)	C3BS-CQR-1 (C-Cure) for heart failure secondary to ischaemic cardiomyopathy
2016	NIHR Horizon Scanning Centre (NIHR HSC)	Siponimod for secondary progressive multiple sclerosis
2016	NIHR Horizon Scanning Centre (NIHR HSC)	Veliparib with carboplatin and paclitaxel for early-stage triple negative breast cancer ─ neoadjuvant therapy
2016	NIHR Health Technology Assessment programme	ImmunoCAP® ISAC and Microtest for multiplex allergen testing in people with difficult to manage allergic disease: a systematic review and cost analysis
2016	NIHR Horizon Scanning Centre (NIHR HSC)	Sofosbuvir, GS-9857 and velpatasvir triple therapy for chronic hepatitis C
2016	NIHR Health Services and Delivery Research programme	Transforming community health services for children and young people who are ill: a quasi-experimental evaluation
2016	NIHR Health Technology Assessment programme	TRAPEZE: a randomised controlled trial of the clinical effectiveness and cost-effectiveness of chemotherapy with zoledronic acid, strontium-89, or both, in men with bony metastatic castration-refractory prostate cancer
2016	NIHR Health Technology Assessment programme	Non-pharmacological treatments for stuttering in children and adults: a systematic review and evaluation of clinical effectiveness, and exploration of barriers to successful outcomes
2016	NIHR Horizon Scanning Centre (NIHR HSC)	Vonicog alfa for severe von Willebrand disease
2016	National Evidence-based Healthcare Collaborating Agency (NECA)	[Comparative effectiveness of carbapenems and alternative antibiotics for the treatment of bacteraemia and/or urinary tract infectious disease by Enterobacteriaceae producing extended-spectrum β-lactamase]
2016	NIHR Horizon Scanning Centre (NIHR HSC)	Ultra-low-dose Danazol (Optina; Vasaloc) for diabetic macular oedema
2016	National Evidence-based Healthcare Collaborating Agency (NECA)	[Advantages of vestibular rehabilitation on the vestibular neuritis]
2016	NIHR Health Technology Assessment programme	Tumour necrosis factor- inhibitors for ankylosing spondylitis and non-radiographic axial spondyloarthritis: a systematic review and economic evaluation
2016	NIHR Horizon Scanning Centre (NIHR HSC)	Latanoprostene bunod for open-angle glaucoma or ocular hypertension – first line
2016	National Evidence-based Healthcare Collaborating Agency (NECA)	[A study on the effectiveness and needs of patient education in patients with rheumatoid arthritis]
2016	Health Sciences Institute in Aragon (IACS)	Effectiveness, security and economic evaluation of existing alternatives for monitoring growth and pubertal development
2016	NIHR Horizon Scanning Centre (NIHR HSC)	Adalimumab (Humira) for uveitis in paediatric patients – second line
2016	National Evidence-based Healthcare Collaborating Agency (NECA)	[Comparison between ICPC (International Classification of Primary Care) classification and ICD (International Classification of Diseases) classification at primary care in Korea]
2016	Health Sciences Institute in Aragon (IACS)	Effectiveness, security and economic evaluation of existing alternatives for the early detection of hypercholesterolemia in the paediatric population.
2016	NIHR Horizon Scanning Centre (NIHR HSC)	Allantoin (Zorblisa) for lesions associated with epidermolysis bullosa – first line
2016	National Evidence-based Healthcare Collaborating Agency (NECA)	[Collaboration Research for development of Trustworthy Clinical Practice Guidelines and evaluation of implementation]
2016	Health Sciences Institute in Aragon (IACS)	Effectiveness, safety and economic evaluation of existing alternatives for the early detection of childhood hearing impairment
2016	NIHR Horizon Scanning Centre (NIHR HSC)	Diclectin (doxylamine succinate and pyridoxine hydrochloride) for the treatment of nausea and vomiting in pregnancy
2016	National Evidence-based Healthcare Collaborating Agency (NECA)	[A health technology evaluation study for reviewing possibility of data linkage]
2016	Health Sciences Institute in Aragon (IACS)	Effectiveness, safety and economic evaluation of existing alternatives for the early detection of arterial hypertension in paediatric population
2016	Health Quality Ontario (HQO)	Skin testing for allergic rhinitis: OHTAC recommendation
2016	Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA)	[Outpatient cardiac rehabilitation part VI: prospective multi-centre cohort study (comparing patients with and without phase III)]
2016	Health Sciences Institute in Aragon (IACS)	Early detection program of health problems between the 0 and 14 years. Effectiveness, Safety and Economic Evaluation of the different existent alternatives in the early detection of alterations of psychomotor development
2016	Health Quality Ontario (HQO)	Vertebral augmentation involving vertebroplasty or kyphoplasty for cancer-related vertebral compression fractures: OHTAC recommendation
2016	NIHR Health Services and Delivery Research programme	Health Equity Indicators for the English NHS: a longitudinal whole-population study at the small-area level
2016	Health Sciences Institute in Aragon (IACS)	Effectiveness, safety and economic evaluation of the existing alternatives for the early detection of Attention Deficit Hyperactivity Disorder (ADHD)
2016	Health Quality Ontario (HQO)	Skin testing for allergic rhinitis: a health technology assessment
2016	NIHR Health Services and Delivery Research programme	Characterising the nature of primary care patient safety incident reports in the England and Wales National Reporting and Learning System: a mixed-methods agenda-setting study for general practice
2016	Health Sciences Institute in Aragon (IACS)	Early detection program of health problems between the 0 and 14 years. Effectivenes, safety and economic evaluation of the different existent alternatives in the early detection of autism spectrum disorders (ASD)
2016	Health Quality Ontario (HQO)	Vertebral augmentation involving vertebroplasty or kyphoplasty for cancer-related vertebral compression fractures: a systematic review
2016	NIHR Public Health Research (PHR) programme	Development and evaluation of an intervention providing insight into the tobacco industry to prevent smoking uptake: a mixed-methods study
2016	Health Sciences Institute in Aragon (IACS)	Effectiveness, safety and economic evaluation of existing alternatives for the early detection of visual impairment in the paediatric population.
2016	NIHR Health Technology Assessment programme	The clinical effectiveness and cost-effectiveness of abatacept, adalimumab, etanercept and tocilizumab for treating juvenile idiopathic arthritis: a systematic review and economic evaluation
2016	Health Quality Ontario (HQO)	Vertebral augmentation involving vertebroplasty or kyphoplasty for cancer-related vertebral compression fractures: an economic analysis
2016	Health Quality Ontario (HQO)	Interventions to improve access to primary care for people who are homeless: a systematic review
2016	HTA Unit, University of Calgary	Laser interstitial thermal therapy for treating intracranial lesions and epilepsy: a health technology assessment and policy analysis
2016	HTA Unit, University of Calgary	Pineal gland cysts: an evidence synthesis
2016	Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA)	[Hepatitis C virus screening in hospitals]
2016	HTA Unit, University of Calgary	Pineal gland cysts: an evidence synthesis summary
2016	Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA)	Atezolizumab (Tecentriq™) for the treatment of locally advanced and metastatic urothelial carcinoma.
2016	HAYES, Inc.	Allogeneic hematopoietic stem cell transplantation for sickle cell disease in children
2016	Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA)	Venetoclax (Venclexta™) for the treatment of relapsed or refractory chronic lymphocytic leukaemia (CLL) with chromosome 17p deletion
2016	HAYES, Inc.	Comparative effectiveness of fiberoptic phototherapy for hyperbilirubinemia in preterm infants
2016	NIHR Horizon Scanning Centre (NIHR HSC)	Atezolizumab in combination with bevacizumab for advanced renal cell carcinoma – first line
2016	HAYES, Inc.	Comparative effectiveness of fiberoptic phototherapy for hyperbilirubinemia in term infants
2016	NIHR Horizon Scanning Centre (NIHR HSC)	Capmatinib for advanced, EGFR wild type, c-Met amplified, non-small cell lung cancer – second or third line
2016	Penn Medicine Center for Evidence-based Practice (CEP)	Guidelines for post-operative opioid prescribing
2016	HAYES, Inc.	Hypoglossal nerve stimulation for the treatment of obstructive sleep apnea
2016	NIHR Horizon Scanning Centre (NIHR HSC)	Denosumab (XGEVA) for hypercalcaemia of malignancy – second line
2016	Penn Medicine Center for Evidence-based Practice (CEP)	Mindfulness-based stress reduction interventions for nurses
2016	NIHR Health Technology Assessment programme	The Men's Safer Sex project: intervention development and feasibility randomised controlled trial of an interactive digital intervention to increase condom use in men
2016	HAYES, Inc.	Implantable cardiac loop recorders for diagnosis and management of syncope in adults
2016	NIHR Horizon Scanning Centre (NIHR HSC)	Depatuxizumab mafodotin for recurrent EGFR-amplified glioblastoma multiforme
2016	HAYES, Inc.	In-hospital patient bathing with 2% chlorhexidine gluconate cloths (Sage Products Inc.) for prevention of hospital-acquired infections
2016	NIHR Horizon Scanning Centre (NIHR HSC)	Ibrutinib (Imbruvica) with rituximab for Waldenström's macroglobulinaemia – untreated or previously treated patients
2016	NIHR Health Technology Assessment programme	Accuracy of fundus autofluorescence imaging for the diagnosis and monitoring of retinal conditions: a systematic review
2016	NIHR Horizon Scanning Centre (NIHR HSC)	Nintedanib (Vargatef) for metastatic colorectal cancer – second and subsequent line
2016	HAYES, Inc.	Intragastric balloons for treatment of obesity
2016	NIHR Horizon Scanning Centre (NIHR HSC)	Nivolumab (Opdivo) and ipilimumab (Yervoy) for advanced or metastatic renal cell carcinoma – first line
2016	Penn Medicine Center for Evidence-based Practice (CEP)	Anticoagulation therapy guidelines for open heart mechanical valve replacement patients
2016	NIHR Horizon Scanning Centre (NIHR HSC)	NBTXR-3 for advanced soft tissue sarcoma – first line
2016	HAYES, Inc.	Low-level laser therapy for carpal tunnel syndrome
2016	NIHR Horizon Scanning Centre (NIHR HSC)	Pertuzumab for metastatic HER2-positive gastric cancer – first line
2016	NIHR Health Technology Assessment programme	The Effectiveness, cost-effectiveness and acceptability of Community versus Hospital Eye Service follow-up for patients with neovascular age-related macular degeneration with quiescent disease (ECHoES): a virtual randomised balanced incomplete block trial
2016	NIHR Horizon Scanning Centre (NIHR HSC)	Masitinib for advanced or metastatic malignant melanoma with a c-kit juxtamembrane mutation
2016	HAYES, Inc.	Magnetic resonance elastography for detecting and staging liver fibrosis
2016	NIHR Horizon Scanning Centre (NIHR HSC)	Ciraparantag for haemorrhage in patients receiving new oral anticoagulants
2016	NIHR Health Technology Assessment programme	tegrated sensor-augmented pump therapy system [the MiniMed® Paradigm™ Veo system and the Vibe™ and G4® PLATINUM CGM (continuous glucose monitoring) system] for managing blood glucose levels in type 1 diabetes: a systematic review and economic evaluation
2016	NIHR Horizon Scanning Centre (NIHR HSC)	Olaparib (Lynparza) for metastatic breast cancer with germline BRCA mutation – second line
2016	HAYES, Inc.	Multimodal Intraoperative Monitoring (MIOM) during surgery for scoliosis and spinal deformities
2016	NIHR Horizon Scanning Centre (NIHR HSC)	Autologous CD34+ hematopoietic stem cells transduced ex vivo with lentiviral vector encoding for the human ADA gene for severe combined immunodeficiency caused by adenosine deaminase deficiency
2016	NIHR Health Technology Assessment programme	Intervention Now to Eliminate Repeat Unintended Pregnancy in Teenagers (INTERUPT): a systematic review of intervention effectiveness and cost-effectiveness, and qualitative and realist synthesis of implementation factors and user engagement
2016	NIHR Health Technology Assessment programme	Clinical effectiveness and cost-effectiveness of use of therapeutic monitoring of tumour necrosis factor alpha (TNF-a) inhibitors [LISA-TRACKER® enzyme-linked immunosorbent assay (ELISA) kits, TNF-a-Blocker ELISA kits and Promonitor® ELISA kits] versus standard care in patients with Crohn's disease: systematic reviews and economic modelling
2016	NIHR Horizon Scanning Centre (NIHR HSC)	Nivolumab (Opdivo) for stage IV or recurrent PD-L1 positive non-small cell lung cancer – first line
2016	HAYES, Inc.	Multimodality Intraoperative Monitoring (MIOM) during cervical spinal surgery
2016	NIHR Horizon Scanning Centre (NIHR HSC)	Diazoxide choline controlled-release for Prader-Willi syndrome – first line
2016	NIHR Horizon Scanning Centre (NIHR HSC)	Nivolumab (Opdivo) for stage IV or recurrent non-small cell lung cancer – first line
2016	HAYES, Inc.	Novocure (tumor treating fields)
2016	NIHR Horizon Scanning Centre (NIHR HSC)	Eculizumab (Soliris) for relapsing neuromyelitis optica spectrum disorders
2016	Penn Medicine Center for Evidence-based Practice (CEP)	Best practices for preventing aspiration pneumonia in hospital patients
2016	NIHR Horizon Scanning Centre (NIHR HSC)	Rucaparib for advanced BRCA-mutated ovarian cancer
2016	HAYES, Inc.	Pelvic floor electrical stimulation for the treatment of urinary incontinence
2016	NIHR Horizon Scanning Centre (NIHR HSC)	XG 102 for post-operative inflammation and pain following cataract surgery
2016	Penn Medicine Center for Evidence-based Practice (CEP)	Endotracheal tubes for subglottic suctioning
2016	NIHR Horizon Scanning Centre (NIHR HSC)	Reolysin for relapsed or refractory multiple myeloma
2016	HAYES, Inc.	Percutaneous pulmonary valve implantation for right ventricular outflow tract defects
2016	NIHR Horizon Scanning Centre (NIHR HSC)	Eculizumab (Soliris) for prevention of delayed graft function after kidney transplantation in adult patients at increased risk – first line
2016	Penn Medicine Center for Evidence-based Practice (CEP)	Faculty development programs for underrepresented minority faculty